Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sentagliptin for Post-stroke Cognitive Impairment in T2DM
NCT07241897Phase 3Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prusogliptin in post-stroke cognitive impairment (PSCI), sponsored by The Second Affiliated Hospital of Soochow University. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
prusogliptin
03
Conditions
post-stroke cognitive impairment (PSCI)
Beyond the preview
Go deeper on NCT07241897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07241897.